62 related articles for article (PubMed ID: 21265082)
1. [Effect of L-arginine and aminoguanidine on morphological characteristics of the lymphocyte plasma membranes during experimental diabetes mellitus].
Brodiak IV; Hnatush AR; Sybirna NO
Fiziol Zh (1994); 2010; 56(5):77-85. PubMed ID: 21265082
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
Dewhurst M; Omawari N; Tomlinson DR
Br J Pharmacol; 1997 Feb; 120(4):593-8. PubMed ID: 9051296
[TBL] [Abstract][Full Text] [Related]
3. [Peculiarities of L-arginine metabolism in the blood leukocytes in experimental diabetes mellitus].
Brodiak IV; Sybirna NO
Fiziol Zh (1994); 2008; 54(1):63-8. PubMed ID: 18416186
[TBL] [Abstract][Full Text] [Related]
4. Effect of supplemental L-arginine on the function of T lymphocytes and the formation of advanced glycosylated end products in rats with streptozotocin-induced diabetes.
Liu CT; Chen KM; Lee SH; Tsai LJ
Nutrition; 2005 May; 21(5):615-23. PubMed ID: 15850969
[TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study.
Sannomiya P; Oliveira MA; Fortes ZB
Br J Pharmacol; 1997 Nov; 122(5):894-8. PubMed ID: 9384505
[TBL] [Abstract][Full Text] [Related]
6. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
Agardh E; Hultberg B; Agardh C
Curr Eye Res; 2000 Jul; 21(1):543-9. PubMed ID: 11035534
[TBL] [Abstract][Full Text] [Related]
7. The role of nitric oxide in diabetes-induced changes of morphine tolerance in rats.
Joharchi K; Jorjani M
Eur J Pharmacol; 2007 Sep; 570(1-3):66-71. PubMed ID: 17599829
[TBL] [Abstract][Full Text] [Related]
8. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
[TBL] [Abstract][Full Text] [Related]
9. Potential prophylactic role of aminoguanidine in diabetic retinopathy and nephropathy in experimental animals.
El Shazly AH; Mahmoud AM; Darwish NS
Acta Pharm; 2009 Mar; 59(1):67-73. PubMed ID: 19304559
[TBL] [Abstract][Full Text] [Related]
10. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
Roufail E; Soulis T; Boel E; Cooper ME; Rees S
Diabetologia; 1998 Dec; 41(12):1419-25. PubMed ID: 9867208
[TBL] [Abstract][Full Text] [Related]
11. Influence of 2,5-dihydroxybenzylidene aminoguanidine on lipid oxidative damage and on antioxidant levels in model diabetes mellitus.
Korytár P; Sivonová M; Maruniaková A; Ulicná O; Kvasnicka P; Liptáková A; Bozek P; Cársky J; Duracková Z
Pharmazie; 2003 Oct; 58(10):733-7. PubMed ID: 14609287
[TBL] [Abstract][Full Text] [Related]
12. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
Wang X; Diao Y; Zhang H; Huo X; Zhang Q
Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400
[TBL] [Abstract][Full Text] [Related]
13. L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus.
El-Missiry MA; Othman AI; Amer MA
J Appl Toxicol; 2004; 24(2):93-7. PubMed ID: 15052603
[TBL] [Abstract][Full Text] [Related]
14. L-arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats.
Méndez JD; Hernández Rde H
Biomed Pharmacother; 2005 Jul; 59(6):283-9. PubMed ID: 15996850
[TBL] [Abstract][Full Text] [Related]
15. Effect of nitric oxide on phagocytic activity of lipopolysaccharide-induced macrophages: possible role of exogenous L-arginine.
Tümer C; Bilgin HM; Obay BD; Diken H; Atmaca M; Kelle M
Cell Biol Int; 2007 Jun; 31(6):565-9. PubMed ID: 17241792
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine.
Nicholls K; Mandel TE
Lab Invest; 1989 Apr; 60(4):486-91. PubMed ID: 2496273
[TBL] [Abstract][Full Text] [Related]
17. [Effect of L-arginine on the endothelium functional activity in experimental diabetes mellitus].
Sahach VF; Prysiazhna OD; Tkachenko MN; Kotsiuruba AV
Fiziol Zh (1994); 2005; 51(2):3-7. PubMed ID: 15943225
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
Gardiner TA; Anderson HR; Stitt AW
J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of aminoguanidine upon capillary and submesothelial anionic sites.
Shostak A; Wajsbrot V; Gotloib L
Microvasc Res; 2001 Mar; 61(2):166-78. PubMed ID: 11254396
[TBL] [Abstract][Full Text] [Related]
20. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats.
Huijberts MS; Wolffenbuttel BH; Boudier HA; Crijns FR; Kruseman AC; Poitevin P; Lévy BI
J Clin Invest; 1993 Sep; 92(3):1407-11. PubMed ID: 8376593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
